Zydus Lifesciences Secures USFDA Approval for Multiple Sclerosis Drug, Concludes Plant Inspection

Zydus Lifesciences, a medicine company, got good news from the US government's health agency, the USFDA.

First, they can now sell a new medicine in the U.S. that helps adults with a condition called multiple sclerosis, which affects the brain and nerves.

This new medicine is a cheaper version of an already existing one.

The company will make it in their factory in Ahmedabad, India.

Also, health inspectors from the USFDA recently visited Zydus' factory that makes cancer medicines.

The inspectors found a couple of things to improve, but they said the company's records were honest.

Zydus plans to fix these issues quickly.

These announcements come after Zydus shared that their business is doing really well, with more money coming in and profits growing.